Skip to main content

How much does Epclusa cost?

Medically reviewed by Philip Thornton, DipPharm. Last updated on June 5, 2024.

Official answer

by Drugs.com

The cost of Epclusa (sofosbuvir and velpatasvir) tablets is roughly $US78,078 for a full 12-week course of treatment. Your cost might vary based on insurance or manufacturer-provided discounts. Epclusa is covered by most insurance plans.

For more information, see Epclusa Prices, Coupons and Patient Assistance Programs.

Epclusa was the first direct-acting oral antiviral agent approved to treat all six major forms of hepatitis C virus (HCV).

Epclusa is used to treat adult and pediatric patients 3 years of age and older with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection:

  • without cirrhosis or with compensated cirrhosis
  • with decompensated cirrhosis for use in combination with ribavirin

Epclusa tablets are used to treat patients weighing at least 17kg. Epclusa oral pellets have also been approved to treat children unable to swallow tablets.

Epclusa is taken once daily for 12 weeks.

Epclusa is a fixed-dose combination containing sofosbuvir and velpatasvir. An authorized generic version of sofosbuvir and velpatasvir tablets was launched in 2019. It is available from Asegua Therapeutics, a subsidiary of the company that also makes Epclusa. At the time of the launch of the generic, the list price for it was $US24,000.

References

Read next

What is the difference between hepatitis B and C?

Some of the main differences between hepatitis B and C are:

  • Hepatitis B virus can be prevented with a vaccine, but not hepatitis C.
  • Hepatitis B and C are different viruses, but you can have both hepatitis B and hepatitis C at the same time.
  • Over 90% of people infected with hepatitis C who have not received treatment can be cured with 8 to 12 weeks of oral medications, but treatment for hepatitis B, if needed, may be long-term or lifelong.
  • There is no cure for hepatitis B, but once you recover from acute hepatitis B, you develop antibodies that protect you from the virus for life.
Continue reading

What are the new drugs for the treatment of hepatitis C?

The newest drugs for the treatment of hepatitis C include Mavyret (glecaprevir and pibrentasvir), Vosevi (sofosbuvir, velpatasvir, and voxilaprevir), and Epclusa (sofosbuvir and velpatasvir). All are FDA-approved for the treatment of chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A), as well as other uses. Continue reading

Does Epclusa work if you miss doses?

There is a chance that Epclusa may not work as well if you miss doses. Epclusa works by interfering with a protein and an enzyme needed by the hepatitis C virus to replicate and if you forget a dose, your blood levels of Epclusa can fall below the level needed to inhibit this protein or enzyme. Continue reading

Related medical questions

Drug information

Related support groups